Adam S. Grossman, President and CEO: Adma Biologics ADMA Sell · Filed 24/11/22

Trade details

Type: Insider sale
Amount: $1,033,203.7
Shares · price: 48,967 sh · $21.10 a share
Held after: 1,989,007 sh
Stock: Adma Biologics ADMA
Person: Adam S. GrossmanPresident and CEO
Trade date: 24/11/22
Filed: 24/11/22
Days to filing: 0 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Adma Biologics trades, last 26 weeks

What else happened in Adma Biologics around then

Filed or reported within 30 days of the trade day · 24/10/23~24/12/22

Adam S. Grossman's recent trades

Adam S. GrossmanPresident and CEO
Sell10b5-1 planAdma Biologics
Sell10b5-1 plan
Adma Biologics
ADMA
$227.4K
15,000 sh
$227.4K
Filed 03/17
Traded 03/16
Adam S. GrossmanPresident and CEO
Sell10b5-1 planAdma Biologics
Sell10b5-1 plan
Adma Biologics
ADMA
$91K
6,000 sh
$91K
Filed 03/17
Traded 03/16
Adam S. GrossmanPresident and CEO
Sell10b5-1 planAdma Biologics
Sell10b5-1 plan
Adma Biologics
ADMA
$241.2K
15,000 sh
$241.2K
Filed 02/17
Traded 02/17
Adam S. GrossmanPresident and CEO
Sell10b5-1 planAdma Biologics
Sell10b5-1 plan
Adma Biologics
ADMA
$96.5K
6,000 sh
$96.5K
Filed 02/17
Traded 02/17
Adam S. GrossmanPresident and CEO
Planned saleAdma Biologics
Planned sale
Adma Biologics
ADMA
$2M
125,000 sh
$2M
Filed 02/17
Traded 02/17

Adam S. Grossman, CEO — sold $1M of Adma Biologics ADMA · 2.4% of holdings | Whalegun